S100B Protein as a Therapeutic Target in Multiple Sclerosis: The S100B Inhibitor Arundic Acid Protects from Chronic Experimental Autoimmune EncephalomyelitisChiara Camponeschi, Gabriele Di Sante, Beatrice Sampaolese et al.|International Journal of Molecular Sciences|2021Cited by 25
Effect on Different Glial Cell Types of S100B Modulation in Multiple Sclerosis Experimental ModelsMaria De Carluccio, Fabrizio Michetti, Gabriele Di Sante et al.|International Journal of Molecular Sciences|2025Cited by 4